Brie N. Noble

Brie N. Noble

Auto-generated profile, based on publicly available information

Brie N. Noble

Department of Pharmacy Practice, Oregon State University/Oregon Health & Science University College of Pharmacy, Portland, Oregon, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2007 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
JCJohn N. Caviness
John N. Caviness
EDErika Driver‐Dunckley
Erika Driver‐Dunckley
DCDonald J. Connor
Donald J. Connor
MSMarwan N. Sabbagh
Marwan N. Sabbagh
JHJoseph G. Hentz
Joseph G. Hentz
CACharles H. Adler
Charles H. Adler

1 December 2009 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
CBCarrie E. Bedient
Carrie E. Bedient
JMJavier F. Magrina
Javier F. Magrina
BNBrie N. Noble
Brie N. Noble
RKRosanne M. Kho
Rosanne M. Kho

1 April 2011 in Gynecologic Oncology
Verified
Journal Article
Closed access
JMJavier F. MAGRINA
Javier F. MAGRINA
VZVanna Zanagnolo
Vanna Zanagnolo
BNBrie N. Noble
Brie N. Noble
RKRosanne M. Kho
Rosanne M. Kho
PMPaul Magtibay
Paul Magtibay

15 April 2010 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
CACharles H. Adler
Charles H. Adler
DCDonald J. Connor
Donald J. Connor
JHJoseph G. Hentz
Joseph G. Hentz
MSMarwan N. Sabbagh
Marwan N. Sabbagh
JCJohn N. Caviness
John N. Caviness
TBThomas G. Beach
Thomas G. Beach

1 September 2007 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
EDErika D. Driver-Dunckley
Erika D. Driver-Dunckley
BNBrie N. Bs Noble
Brie N. Bs Noble
JHJoseph G. Hentz
Joseph G. Hentz
VEVirgilio G.H. Evidente
Virgilio G.H. Evidente
JCJohn N. Caviness
John N. Caviness
CACharles H. Adler
Charles H. Adler
Objectives: Do patients with restless legs syndrome (RLS) report gambling or other abnormal behaviors as previously reported in Parkinson disease. Methods: This survey study was sent to 261 idiopathic RLS patients, and it included the Gambling Symptoms Assessment Scale, Altman Self-Rating Mania Scale, and questions pertaining to sexual activity and novelty-seeking behaviors. Results: Ninety-nine patients responded to the survey, and 77 were actively taking 1 or more dopaminergic medications. Of the 70 respondents who answered the gambling questions, 5 (7%) noted a change in gambling, with 4 (6%; 95% confidence interval, 2%-14%) stating that increased urges and time spent gambling occurred specifically after the use of dopaminergic medications (2 on pramipexole, 1 on ropinirole, and 1 on levodopa and pramipexole). Increased sexual desire was reported by 4 (5%) of the 77 respondents, 3 (4%; 95% confidence interval, 1%-11%) reported that this occurred specifically after the use of dopaminergic medications (1 on pramipexole, 1 on ropinirole, and 1 on levodopa). One patient reported both an increase in gambling and sexual habits. Conclusions: This exploratory survey study revealed the development of gambling and/or increased sexuality in patients with RLS. These data raise the possibility that, as in Parkinson disease, RLS patients should be cautioned about potential behaviors that may occur with the use of dopaminergic medications. Further prospective studies are needed to assess the relationship between these medications and compulsive behaviors associated with the treatment of RLS.

1 December 2013 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
JRJoseph H. Rosenberg
Joseph H. Rosenberg
JAJennifer S. Albrecht
Jennifer S. Albrecht
EFErik K. Fromme
Erik K. Fromme
BNBrie N. Noble
Brie N. Noble
JMJessina C. McGregor
Jessina C. McGregor
JFJon P. Furuno
Jon P. Furuno
Background: Patients receiving hospice or palliative care often receive antimicrobial therapy; however the effectiveness of antimicrobial therapy for symptom management in these patients is unknown. Objective: The study's objective was to systematically review and summarize existing data on the prevalence and effectiveness of antimicrobial therapy to improve symptom burden among hospice or palliative care patients. Design: Systematic review of articles on microbial use in hospice and palliative care patients published from January 1, 2001 through June 30, 2011. Measurements: We extracted data on patients' underlying chronic condition and health care setting, study design, prevalence of antimicrobial use, whether symptom response following antimicrobial use was measured, and the method for measuring symptom response. Results: Eleven studies met our inclusion criteria in which prevalence of antimicrobial use ranged from 4% to 84%. Eight studies measured symptom response following antimicrobial therapy. Methods of symptom assessment were highly variable and ranged from clinical assessment from patients' charts to the Edmonton Symptom Assessment Scale. Symptom improvement varied by indication, and patients with urinary tract infections (two studies) appeared to experience the greatest improvement following antimicrobial therapy (range 67% to 92%). Conclusion: Limited data are available on the use of antimicrobial therapy for symptom management among patients receiving palliative or hospice care. Future studies should systematically measure symptom response and control for important confounders to provide useful data to guide antimicrobial use in this population.